The Antibody Society

the official website of the antibody society

An international non-profit supporting antibody-related research and development.

  • LOG IN
  • BECOME A MEMBER
  • About
    • Mission & Activities
    • Board of Directors
    • Our Staff & Volunteers
    • The Antibody Society’s Standing Committees
      • AIRR Community Committee
      • Communication & Membership Committee
      • Initiatives Committee
      • Meetings Committee
    • Sponsors & Partners
  • Society meetings
    • Biopharmaceutical Informatics Symposium
    • Harnessing Cytokines for Cancer Immunotherapy Symposium
    • Emerging Cancer Therapies Leveraging Gamma-Delta Effector T cells Symposium
    • Emerging Immunotherapeutics for Ovarian Cancer Symposium
    • AIRR Community Meetings
    • Antibody Engineering & Therapeutics (US) 2022
      • 2020 Antibody Engineering & Therapeutics
      • 2019 Antibody Engineering & Therapeutics
      • 2018 Antibody Engineering & Therapeutics
      • What is INN a Name?
        • INN issue updates
    • Antibody Engineering & Therapeutics Europe 2022
    • FOCIS Symposia
  • AIRR Community
    • AIRR News
    • AIRR Publications
    • AIRR Meetings
      • AIRR Community Meeting VI: “Exploring New Frontiers”
      • AIRR Community Meeting V: “Zooming in to the AIRR Community”
      • AIRR Community Meeting V Pre-Meetings
        • AIRR-seq in the Pandemic
        • AIRR-seq Biological Standards and Workflows
      • AIRR Community Special Event: “Response to COVID-19”
      • AIRR Community Meeting IV: “Bridging the Gaps”
      • AIRR Community Meeting III
        • Day 1
        • Day 2
        • Day 3
        • Day 4
      • AIRR Community Meeting II
      • AIRR Community Meeting I
    • AIRR Community Working Groups
      • Biological Resources Working Group
      • Common Repository Working Group
      • Diagnostics Working Group
      • Germline Database Working Group
      • Legal and Ethics Working Group
      • Software Working Group
      • Standards Working Group
    • AIRR Community Sub-committees
      • Communications Sub-committee
      • Executive Sub-committee
      • Inferred Allele Review Committee
      • Meetings Sub-committee
    • AIRR Data Commons
    • AIRR Community Calendar
    • AIRR Community Webinar Series
    • On AIRR – An AIRR Community Podcast
    • AIRR Community Resources
    • AIRR Community Service Prize 2022
  • Members only
    • Login
    • Note to members
    • James S. Huston Antibody Science Talent Award
      • 2020 James S. Huston Antibody Science Talent Award Recipient
      • JSH Award Criteria
    • Research Competitions
      • Research Competition Winners
    • Science Writing Competition
      • Science Writing Competition Winners
    • Member discount codes
    • Antibodies in early-stage studies
    • Presentations
  • Upcoming meetings
  • Web Resources
    • Society Publications
    • Antibody News
    • Antibody therapeutics approved or in regulatory review in the EU or US
      • Antibody therapeutics product data
    • Antibodies in late-stage clinical studies
    • Research Resources
    • Education Resources
  • Career Center
    • Career Shorts
  • Learning Center
    • Upcoming Webinars
    • Snakebite antivenoms: Global challenges and progress toward recombinant antibody therapeutics
    • Adaptive Immune Receptor Repertoires
    • Antibody Discovery & Development
    • Commercializing Antibody Therapeutics
    • Antibodies to Watch
    • Antibody Validation
  • COVID-19
    • Guide to “Coronavirus in the Crosshairs”
    • COVID-19 Biologics Tracker
    • Meeting Report: The Diagnostic Landscape for COVID-19
You are here: Home / Upcoming meetings

Upcoming meetings

The Antibody Society has partnered with numerous conference organizers, including Informa Connect, Cambridge Healthtech Institute, Hanson Wade, and Terrapinn, to ensure our members receive substantial discounts on meeting registration fees. As a courtesy, we also list meetings held by non-profit organizations, such as Gordon Research Conferences and KeyStone Symposia.

In 2022, we have also partnered with Schrödinger, and are pleased to offer 10% discounts to our members for their online course, Introduction to Computational Antibody Engineering.

Schrödinger’s online course, Introduction to Computational Antibody Engineering, will show how industry-leading computational molecular modeling solutions are used to aid in antibody discovery and design and how to incorporate these computational approaches into your research project. This course will also provide a chance to work hands-on with Schrödinger’s BioLuminate software.

Upcoming 2022 Session Dates:
September 12th, 10:00 AM ET – October 19th, 4:59 PM ET
November 7th, 10:00 AM ET – December 14th, 4:59 PM ET

The Antibody Society members save 10% off your booking – contact membership@antibodysociety.org for the discount code. With no discount, the course fee is $475 for non-student users and $350 for student users.





August 2022



Join industry pioneers revolutionizing antibodies, linkers and payloads from data driven research for this one-day digital event!
The Antibody Society is an official media partner for Antibody Drug Conjugates 2022. This brand-new virtual event taking place on August 10, 2022, brings you a must-see line-up of industry names that you won’t want to miss.

What you can expect:

  • Gain an understanding of toxicity mechanisms to improve safety and reduce off-target effects
  • Learn improved approaches for intelligent drug design strategy
  • Identify novel tumor targets to broaden the scope and improve the therapeutic outcome for ADC drugs
  • Recognize rapid characterization methods to identify and investigate new bioconjugation sites

Don’t miss out! See the full agenda and learn more here.

Register here –  Save £400 with early bird pricing and secure your place for only £399 if you book before midnight Friday July 22.

Secure your place today with an extra 15% discount – contact membership@antibodysociety.org for the discount code.

 



September 2022



13th Annual World ADC San Diego (September 6-9)

Running for the first time in-person since 2019, the hotly anticipated 13th World ADC San Diego is back, bigger and better than ever before.

With a continued dedication to curating scientific insights and transformative lessons to maximizing the clinical therapeutic index of your ADC, this year’s meeting delves further into the resurgence of ADCs being used as combination therapies, next generation payloads, and how to evolve your manufacturing processes in this fast-paced and ever-evolving field.

As your global one stop shop for antibody drug conjugates from early discovery to late phase manufacturing, join AstraZeneca, Genentech, Mersana Therapeutics, Sutro Biopharma, Daiichi Sankyo and many more to gain updates from the dynamic nonclinical and clinical environment.

Access your copy of brand-new full event guide with 100+ world class speakers.

This is your ultimate platform to meet face-to-face with 600+ pioneers at the forefront of ADC R&D and foster vital scientific exchange and communication to propel these life-saving therapeutics to more patients now.

To join our longstanding ADC community in sunny San Diego, register your place here.

Antibody Society members save 10% on their booking – contact membership@antibodysociety.org for the discount code.



13th Annual World Multispecifics Summit

September 20 – 22, 2022 | Boston, MA

The Newly Re-Branded 13th World Multispecifics Summit returns this September as the only end-to-end meeting committed solely to advancing the development of bi- & multi-specific therapeutics.

This world-renowned forum will deliver a greater scope and penetration of innovative technical content than any other meeting. This year’s re-imagined agenda will cover unique target discovery, mechanistic diversity and translational science as well as novel formats, product design and manufacturability challenges faced in the bispecific field.

Download the full event guide here

Whatever your role or interest, you will leave the meeting with concrete methods to employ in your strategy and pipeline to convert the promise of bi- and multi-specific therapeutics into a reality for patients.

Early bird and group discounts available – see the pricing information here.

Antibody Society members save 10% on their booking  – contact membership@antibodysociety.org for the discount code.

 



Next Generation Protein Therapeutics Summit returns to Boston, September 28 – 30, 2022.

This is your opportunity to network with like-minded peers in the industry who are looking at the cutting-edge research on the next generation of proteins and molecules. Swap tips and business cards with pioneers in the field and dive into the critical insights that will pave the way for your next break-through.

Dive into critical topics, including:

  • Bioconjugate Design and Challenges
  • Multispecific Design and Challenges
  • T Cell Engager Design and Challenges
  • Engineering and Designing Scaffolds As Therapeutics
  • Protein Engineering Techniques and
  • Workflows for Improved Protein Design
  • New Targets & Target Specificity
  • Solutions for Unmet Drug Delivery Challenges
  • Clinical Progress for Beyond Antibodies
  • AI/ML & Next Generation Sequencing for the Future of Protein Engineering & Design

Get 15% off as an Antibody Society member! Contact membership@antibodysociety.org for the discount code.



December 2022



Join us in San Diego for the next Antibody Engineering & Therapeutics meeting!

Dive into brand new topic streams in 2022 that will cover key areas in industry:

  • Antibody engineering, libraries and selection (including HTS)
  • Machine learning/artificial intelligence in antibody discovery and engineering
  • Fc-engineering & other (non IgG1/IgG4) subclasses
  • Antibody-drug conjugates
  • Advancing antibody therapeutics in immuno-oncology
  • Tumor microenvironment (including immunocytokines)
  • Novel/difficult targets for antibody therapeutics (e.g. MHCp, GPRC, glycans)
  • How to develop an antibody-based drug: from discovery to IND?
  • Adaptive immune receptor repertoire data processing, annotation and interpretation
  • Antibodies in non-cancer (Autoimmune, neurological and other diseases)
  • Functional Screening Integrated Into Initial Antibody Discovery
  • Antibody-drug conjugates, toxins and other conjugates
  • Cellular therapies: CART’s (T and NK) (non-cell engaging)
  • Bispecifics / multispecifics / combinations (non-cell engaging)
  • Antibodies in Infectious diseases
  • T cell (including gamma/delta) and NK cell engagers

Don’t miss out! See the full agenda and learn more here.

Register here for the in-person event.

Register here for the digital event.

Secure your place today with an extra 15% discount – contact membership@antibodysociety.org for the discount code.

mabs

mabs

The Official Journal of The Antibody Society

Career Center

Our Career Center is a premier resource to connect highly qualified talent with matching career opportunities. Visit for details on over 800 jobs!

AIRR Community

AIRR Community

The Adaptive Immune Receptor Repertoire Community is a research-driven group organizing around the use of high-throughput sequencing technologies to study antibody/B-cell and T-cell receptor repertoires.

Recent Posts

  • The Society has selected mAbs as its Official Journal! July 29, 2022
  • Congratulations to our 2022 Antibody Research Competition winners! July 26, 2022
  • Register for our upcoming webinar on BLI and its use in anti-snake venom antibody discovery July 19, 2022

Archives

Follow us online

  • Email
  • LinkedIn
  • Twitter
  • YouTube
  • Home
  • Privacy & Terms of Use
  • About
  • Board of Directors
  • Advisors
  • Sponsors & Partners
  • Mission & Activities
  • Join the Society
  • Membership Levels
  • Members only
  • Login
  • Antibody therapeutics approved or in regulatory review in the EU or US
  • Meeting reports
  • Presentations
  • Contact

©2015 - scicomvisuals